<HTML>

<FONT FACE="Arial" SIZE=3><P ALIGN="RIGHT"><A NAME="EXHIBIT99a">
Exhibit 99(a)</P>
<P ALIGN="JUSTIFY"></A></P>
<B><P ALIGN="CENTER">BERGEN BRUNSWIG CORPORATION</P>
<P ALIGN="CENTER">STATEMENT REGARDING FORWARD-LOOKING INFORMATION</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">The  Private  Securities  Litigation  Reform Act
of 1995 (the  "Act") provides a "safe harbor" for "forward-looking
statements" (as defined in the Act). The Form 10-K to which this exhibit
is attached, the Company' s Annual Report to Shareowners, any Form 10-K,
any other Form 10-Q or any Form 8-K of the Company, or any other written
or oral statements made by or on behalf of the Company may include forward-looking
statements which reflect the Company's current view (as of the date such
forward-looking statement is made) with respect to future events, prospects,
projections or financial performance.  These  forward-looking statements are
subject to certain uncertainties and other factors that could cause actual
results to differ materially from those made, implied or projected in such
statements. These uncertainties and other factors include, but are not limited
to, uncertainties relating to general economic conditions; the loss of one or
more key customer or supplier relationships, including pharmaceutical or
medical-surgical manufacturers for which alternative supplies may not be
available; the malfunction or failure of the Company's information systems,
including malfunctions or failures associated with Year 2000 compliance or
readiness issues; the costs and difficulties related to the integration of
recently acquired  businesses, including the status of such businesses'
compliance with Year 2000 protocols and such businesses to produce earnings
that were anticipated or planned for; changes to the presentation of financial
results and position resulting from adoption of new accounting principles or
upon the advice of the Company's independent auditors, or the staff of the
Securities and Exchange Commission; changes in the distribution or outsourcing
pattern for pharmaceutical or medical-surgical products and/or services, including
any increase in direct distribution or decrease in contract packaging by
pharmaceutical manufacturers; application of, changes in, or failure to comply
with, government regulations; the costs and other effects of legal and administrative
proceedings and governmental audits including various pending litigation matters and
the Bergen securities cases as described and defined in Part 1, Item 3 entitled "Legal
Proceedings" of this Annual Report; competitive factors in the Company's
healthcare service businesses, including pricing pressures; the continued financial
viability and success of the Company's customers and suppliers; technological
developments and products offered by competitors; failure to retain or continue
to attract senior management or key personnel; risks associated with international
operations; including fluctuations in currency exchange ratios; successful
challenges to the validity of the Company's patents, copyrights and/or trademarks;
difficulties or delays in the development, production and marketing of new products
and services; strikes or other labor disruptions; labor and employee benefit costs;
injuries to persons or property resulting from the operation of the Company's business;
pharmaceutical and medical-surgical manufacturers' pricing policies and overall drug
and medical-surgical supply price inflation; changes in buying practices of hospital
buying groups or hospitals; availability and cost of attractive acquisition candidates;
the continuation of various trends in the long-term care market (including the trends
toward consolidation, cost containment and the implementation of the Medicare
prospective payment system); the effect of reforms of the health care delivery
system; and other factors referenced in the Form 10-K to which this exhibit is
attached or other filings or written or oral statements made by or on behalf of
the Company. The words "believe", "expect", "anticipate", "project", and similar
expressions identify "forward-looking statements", which speak only as of the date
the statement was made. The Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of new information, future
events or otherwise. </P>
</FONT></BODY>
</HTML>